Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir

Title
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir
Authors
Keywords
Direct-Acting Antivirals, ION-1, ION-2, ION-3
Journal
GASTROENTEROLOGY
Volume 151, Issue 3, Pages 501-512.e1
Publisher
Elsevier BV
Online
2016-06-14
DOI
10.1053/j.gastro.2016.06.002

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation